CMPO vs RARE · rev $420.6M vs rev $350.0M
CompoSecure, Inc. (CMPO) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
CompoSecure, Inc. (CMPO) is a metal fabrication company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CMPO revenue for 2024-12-31 was $420.6M. Net income was -$83.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. CMPO currently screens at market cap $7.28B.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CMPO currently screens at market cap $7.28B. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CMPO and RARE stock pages for the full models.
Not investment advice.